Intracardiac masses refer to abnormal growths or deposits within the chambers of the heart. These masses can vary widely in their composition and origin, ranging from benign tumors and blood clots to more serious conditions such as cancers. The presence of intracardiac masses can pose significant challenges to cardiac function, potentially affecting blood flow, leading to complications such as embolism or obstruction. Diagnostic techniques such as echocardiography and cardiac MRI play a crucial role in identifying and characterizing these masses, enabling healthcare professionals to determine the most appropriate course of treatment. Management strategies may involve medical therapies, surgical intervention, or a combination of approaches, depending on the nature and severity of the intracardiac mass. Timely detection and intervention are essential in addressing intracardiac masses and preserving overall cardiac health.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India